Foxa2 has been identified as an insulin-sensitive transcriptional regulator that modulates gene expression involved in glucose and lipid metabolism pathways and improves insulin resistance in peripheral tissues (Le Lay & Kaestner, 2010; Puigserver & Rodgers, 2006; Wolfrum et al., 2004). The gene discussed is FOXA2; the disease is Insulin resistance.